Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration

被引：0
|
作者：
Venzara, Frank [1 ]
Mason, John [1 ]
Glover, Jay [2 ]
McGwin, Gerald [1 ,3 ]
Huisingh, Carrie [3 ]
Friedman, Duncan [1 ]
Feist, Richard [1 ]
Thomley, Martin [1 ]
Albert, Michael [1 ]
Price, Natalie [1 ]
机构：
[1] Univ Alabama Birmingham, Retina Consultants Alabama, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
412 age-related macular degeneration; 688; retina; 462 clinical (human) or epidemiologic studies: outcomes/complications;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3801
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Outcomes after switching eyes that were stable on aflibercept to ranibizumab versus continuing aflibercept in neovascular age-related macular degeneration
    Mirataollah Salabati
    Anthony Obeid
    Raziyeh Mahmoudzadeh
    Omesh Gupta
    Allen Chiang
    Marc Spirn
    Michael A. Klufas
    Jason Hsu
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2509 - 2516
  • [32] Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration
    Lee, In Ho
    Lee, Jae Jung
    Kwon, Han Jo
    Park, Sung Who
    Lee, Ji Eun
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (01): : 40 - 46
  • [33] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88
  • [34] Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration
    Gupta, Bhaskar
    Adewoyin, Temilade
    Patel, Sheryl-Kay
    Sivaprasad, Sobha
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (03) : 386 - 390
  • [35] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Ian J Constable
    Ian L McAllister
    Timothy Isaacs
    [J]. International Journal of Ophthalmology, 2011, (01) : 85 - 88
  • [36] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [37] Long-term outcomes of intravitreal aflibercept in neovascular age-related macular degeneration with pigment epithelial detachments refractory to ranibizumab and bevacizumab
    Huo, Siya
    Chau, Felix Yan-Fay
    Lim, Jennifer I.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [38] Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept
    Kaya, F.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (10): : 832 - 838
  • [39] Intravitreal Bevacizumab and Aflibercept for the Treatment of Exudative Age-Related Macular Degeneration
    Selid, Paul D.
    Jundt, Michael C.
    Fortney, Aaron C.
    Beal, James R.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (04): : 275 - 281
  • [40] Intravitreal bevacizumab for neovascular age-related macular degeneration
    Ladewig, M. S.
    Ziemssen, F.
    Jaissle, G.
    Helb, H. -M.
    Scholl, H. P. N.
    Eter, N.
    Bartz-Schmidt, K. U.
    Holz, F. G.
    [J]. OPHTHALMOLOGE, 2006, 103 (06): : 463 - +
12345